Retro and retroenantio analogs of cecropin-melittin hybrids.
Open accessThe DOI matches its Crossref record.
Abstract
Hybrid analogs of cecropin A (CA) and melittin (M), which are potent antibacterial peptides, have been synthesized. To understand the structural requirements for this antibacterial activity, we have also synthesized the enantio, retro, and retroenantio isomers of two of the hybrids and their N-terminally acetylated derivatives. All analogs of CA(1-13)M(1-13)-NH2 were as active as the parent peptide against five test bacterial strains, but one bacterial strain was resistant to the retro and retroenantio derivatives. Similarly, all analogs of CA(1-7)M(2-9)-NH2 were active against four strains, while two strains were resistant to the retro and retroenantio analogs containing free NH3+ end groups, but acetylation restored activity against one of them. From these data it was concluded that chirality of the peptide was not a critical feature, and full activity could be achieved with peptides containing either all L- or all D-amino acids in their respective right-handed or left-handed helical conformations. For most of the bacterial strains, the sequence of these peptides or the direction of the peptide bonds could be critical but not both at the same time. For some strains, both needed to be conserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mode of action of membrane active antimicrobial peptides
Shai, Y. (2002) · Peptide Science · doi:10.1002/bip.10260 · Cited by 1,576
Amphipathic, α-helical antimicrobial peptides
Tossi, A., Sandri, L., & Giangaspero, A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)55:1<4::aid-bip30>3.0.co;2-m · Cited by 1,247
Antibacterial peptides: basic facts and emerging concepts
Boman, H. G. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01228.x · Cited by 1,158
Self-citationPark, C. B., Kim, H. S., & Kim, S. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8159 · Cited by 896
Prevention of Intravascular Catheter-Related Infections
(2021) · Indian Journal of Continuing Nursing Education · doi:10.4103/2230-7354.320831 · Cited by 855
Melittin: a Membrane-active Peptide with Diverse Functions
Raghuraman, H., & Chattopadhyay, A. (2007) · Bioscience Reports · doi:10.1007/s10540-006-9030-z · Cited by 651
Giangaspero, A., Sandri, L., & Tossi, A. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2001.02494.x · Cited by 636
Animal antimicrobial peptides: An overview
Andreu, D., & Rivas, L. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<415::aid-bip2>3.0.co;2-d · Cited by 618
Self-citationAgeitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
Sato, H., & Feix, J. B. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.02.021 · Cited by 522
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Mimicry of Host-Defense Peptides by Unnatural Oligomers: Antimicrobial β-Peptides
Porter, E. A., Weisblum, B., & Gellman, S. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0260871 · Cited by 379
Moreno, M., & Giralt, E. (2015) · Toxins · doi:10.3390/toxins7041126 · Cited by 375
From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides
Shai, Y., & Oren, Z. (2001) · Peptides · doi:10.1016/s0196-9781(01)00498-3 · Cited by 370
Prevention of Vascular and Neural Dysfunction in Diabetic Rats by C-Peptide
Ido, Y., Vindigni, A., Chang, K., Stramm, L., Chance, R., Heath, W. F., DiMarchi, R. D., Di Cera, E., & Williamson, J. R. (1997) · Science · doi:10.1126/science.277.5325.563 · Cited by 341
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
Antibacterial peptides isolated from insects
Otvos, Jr. (2000) · Journal of Peptide Science · doi:10.1002/1099-1387(200010)6:10<497::aid-psc277>3.0.co;2-w · Cited by 286
Hong, S. Y., Oh, J. E., & Lee, K.-H. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00259-2 · Cited by 274
YADAMP: yet another database of antimicrobial peptides
Piotto, S. P., Sessa, L., Concilio, S., & Iannelli, P. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.12.003 · Cited by 253
Schmidt, N. W., & Wong, G. C. L. (2013) · Current Opinion in Solid State and Materials Science · doi:10.1016/j.cossms.2013.09.004 · Cited by 194
“Support for this comes from studies showing that AMPs composed of D amino acids showed identical antibacterial and hemolytic activities to their all-L natural versions, indicating specific interactions with chiral membrane receptors and enzymes are not responsible for activity [38–41].”
ResultChemical modifications to increase the therapeutic potential of antimicrobial peptides
Han, Y., Zhang, M., Lai, R., & Zhang, Z. (2021) · Peptides · doi:10.1016/j.peptides.2021.170666 · Cited by 165
Zhou, J., Du, X., Li, J., Yamagata, N., & Xu, B. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b06181 · Cited by 151
Topological mimicry of cross-reacting enantiomeric peptide antigens
Verdoliva, A., Ruvo, M., Cassani, G., & Fassina, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30422 · Cited by 30
Iwai, L. K., Duranti, M. A., Abel, L. C. J., Juliano, M. A., Kalil, J., Juliano, L., & Cunha-Neto, E. (2001) · Peptides · doi:10.1016/s0196-9781(01)00409-0 · Cited by 16
Metadata
- Authors
- Merrifield, R. B., Juvvadi, P., Andreu, D., Ubach, J., Boman, A., & Boman, H. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-04-11
- Volume
- 92
- Issue
- 8
- Pages
- 3449-3453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2169459642
- Cited by
- 149
- References
- 0
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.